B
Bioventus Inc.
BVS · NASDAQ · Healthcare · 966M
Closing price
$13.06
+2.96% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
38.3×
Price / net assetsP/B
3.8×
Enterprise value / EBITDAEV/EBITDA
11.4×
Free cash flow yieldFCF yield
8.2%
Return on equityROE
12.3%
Operating margin
10.3%
Net debt / EBITDAbalance-sheet strength
2.6×
Interest coverage
2.2×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.